Suven Life Sciences Ltd Performance
Day's Low
Day's High
₹116.56₹120.9952 Week's Low
52 Week's High
₹74.5₹169.3
| Returns % | |
| 1 Month Return | -1.79 % |
| 3 Month Return | -17.85 % |
| 1 Year Return | + 41.57 % |
| Market Stats | |
| Previous Close | ₹120.97 |
| Open | ₹120.90 |
| Volume | 77.02K |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹2,638.04Cr |
Suven Life Sciences Ltd Key Statistics
| P/E Ratio | -18.06 |
| PEG Ratio | 19.01 |
| Market Cap | ₹2,638.04 Cr |
| P/B Ratio | 2.57 |
| EPS | -4.82 |
| Dividend Yield | 0 |
| Sector | Healthcare |
| ROE | -2.36 |
Suven Life Sciences Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹2,638.04 Cr | 142.81% | 0.50 | -₹106 Cr | ₹11 Cr | |
| BUY | ₹25,790.33 Cr | 64.12% | 0.69 | ₹789 Cr | ₹5,018 Cr | |
| NA | ₹80.50 Cr | 34.74% | 0.56 | -₹2 Cr | ₹39 Cr | |
| NA | ₹39.83 Cr | 32.5% | 1.33 | ₹2 Cr | ₹10 Cr | |
| NA | ₹3,806.60 Cr | 174.5% | 0.56 | NA | NA |
About Suven Life Sciences Ltd
Share Price: ₹118.09 per share as on 21 Nov, 2024 04:01 PM
Market Capitalisation: ₹2,638.04Cr as of today
Revenue: ₹2.57Cr as on September 2024 (Q3 24)
Net Profit: ₹-49.64Cr as on September 2024 (Q3 24)
Listing date: 23 Oct, 2003
Chairperson Name: Venkateswarlu Jasti
| Organisation | Suven Life Sciences Ltd |
| Headquarters | Hyderabad |
| Industry | Healthcare |
| E-voting on shares | Click here to vote |
Key events for Suven Life Sciences Ltd
Suven and Cohance Set Revenue Growth Targets - 01 Nov, 2024
Suven Pharmaceuticals and Cohance Lifesciences plan to more than double their combined revenue to Rs 6,000 crore by FY29 through organic and inorganic growth. The merger has received NSE and BSE approval, with a shareholders meeting scheduled for November 28, 2024. The new entity will focus on expanding its pharmaceutical CDMO, specialty chemicals CDMO, and APIs, capitalizing on rising global demand.
Suven Life Sciences Reports Decline in Sales and Losses - 30 Oct, 2024
Suven Life Sciences reported standalone net sales of Rs 2.57 crore for September 2024, a 15.91% decline YoY, with a net loss of Rs 11.07 crore. The company's EBITDA also turned negative. Despite these results, shares closed at Rs 117.89, reflecting a 5.87% return over six months and 56.15% over twelve months.
Suven Life Sciences Reports Significant Losses - 29 Oct, 2024
Suven Life Sciences Limited reported disappointing earnings for Q2 and six months ended September 30, 2024, with a net loss of INR 496.44 million and INR 776.84 million, respectively, reflecting a decline in sales and revenue compared to the previous year.
Insights on Suven Life Sciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 28.12% to 28.34% in Sep 2024 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 5.01 Cr → 6.61 Cr (in ₹), with an average increase of 24.2% per quarter
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 98.7%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.27% of holdings in Sep 2024 quarter
- NO EFFECT
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 17.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, -26.54 Cr → -49.64 Cr (in ₹), with an average decrease of 41.3% per quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, SUVEN stock has moved down by -17.9%
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 0.45% to 0.34% in Sep 2024 quarter
Suven Life Sciences Ltd Financials
Index Inclusions
Suven Life Sciences Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 70.27% | 0.00 | |
| Foreign Institutions | 0.34% | ||
| Mutual Funds | 1.05% | 0.04 | |
| Retail Investors | 28.34% | 0.80 | |
| Others | 0% |
Suven Life Sciences Ltd Key Indicators
Suven Life Sciences Ltd Valuation
Suven Life Sciences Ltd in the last 5 years
Lowest (-165.11x)
February 27, 2020
Today (-18.06x)
November 19, 2024
Industry (96.41x)
November 19, 2024
Highest (-6.67x)
March 27, 2023
Suven Life Sciences Ltd Earnings and Dividends
Suven Life Sciences Ltd Earnings Results
Suven Life Sciences Ltd’s net profit fell -291.48% since last year same period to ₹-49.64Cr in the Q2 2024-2025. On a quarterly growth basis, Suven Life Sciences Ltd has generated -77.03% fall in its net profits since last 3-months.
Read More about Earnings ResultsSuven Life Sciences Ltd Dividends February,2019
In the quarter ending December 2018, Suven Life Sciences Ltd has declared dividend of ₹1.50 - translating a dividend yield of 1.24%.
Read More about Dividends
Suven Life Sciences Ltd Technicals Summary
Bearish
Neutral
Bullish
Suven Life Sciences Ltd is currently in a Bearish trading position according to technical analysis indicators.
FAQs on Suven Life Sciences Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Suven Life Sciences Ltd shares.
Suven Life Sciences Ltd (SUVEN) share price today is ₹118.09
Suven Life Sciences Ltd is listed on NSE
Suven Life Sciences Ltd is listed on BSE
- Today’s highest price of Suven Life Sciences Ltd is ₹120.99.
- Today’s lowest price of Suven Life Sciences Ltd is ₹116.56.
PE Ratio of Suven Life Sciences Ltd is -18.06
PE ratio = Suven Life Sciences Ltd Market price per share / Suven Life Sciences Ltd Earnings per share
Today’s traded volume of Suven Life Sciences Ltd(SUVEN) is 77.02K.
Today’s market capitalisation of Suven Life Sciences Ltd(SUVEN) is ₹2638.04Cr.
| Suven Life Sciences Ltd(SUVEN | Price |
|---|---|
52 Week High | ₹169.3 |
52 Week Low | ₹74.5 |
Suven Life Sciences Ltd(SUVEN) share price is ₹118.09. It is down -30.25% from its 52 Week High price of ₹169.3
Suven Life Sciences Ltd(SUVEN) share price is ₹118.09. It is up 58.51% from its 52 Week Low price of ₹74.5
| Suven Life Sciences Ltd(SUVEN | Returns |
|---|---|
1 Day Returns | -2.88% |
1 Month Returns | -1.79% |
3 Month Returns | -17.85% |
1 Year Returns | 41.57% |